Lana Medical Company (TADAWUL:9587)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
30.10
-1.42 (-4.51%)
Oct 8, 2025, 2:35 PM AST

Lana Medical Company Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
163160115--
Market Cap Growth
20.72%38.75%---
Enterprise Value
172165120--
Last Close Price
30.1029.6021.33--
PE Ratio
13.0412.83---
PS Ratio
1.931.902.37--
PB Ratio
2.662.622.36--
P/TBV Ratio
2.672.632.37--
P/OCF Ratio
413.37406.51112.52--
EV/Sales Ratio
2.041.962.47--
EV/EBITDA Ratio
9.9014.74107.83--
EV/EBIT Ratio
12.4019.44---
Debt / Equity Ratio
0.250.250.230.160.21
Debt / EBITDA Ratio
1.291.297.110.941.04
Debt / FCF Ratio
---15.15-
Asset Turnover
0.940.940.700.68-
Inventory Turnover
15.4415.448.345.37-
Quick Ratio
1.471.472.383.344.52
Current Ratio
1.871.873.034.165.39
Return on Equity (ROE)
22.70%22.70%-4.00%12.34%-
Return on Assets (ROA)
5.92%5.92%-0.33%6.77%-
Return on Capital (ROIC)
7.76%7.76%-0.40%7.75%-
Return on Capital Employed (ROCE)
11.80%11.80%-12.40%14.80%
Earnings Yield
7.67%7.80%-1.67%--
FCF Yield
-2.29%-2.33%-2.11%--
Buyback Yield / Dilution
--18.38%-1.37%-37.11%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.